Navigation Links
Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
Date:3/12/2009

hase 2 clinical trial in patients with non-Hodgkin's lymphoma with blinatumomab. In addition, by mid-2009, we expect to have completed enrollment in the ongoing phase 2 clinical trial in patients with acute lymphoblastic leukemia.
  • By mid 2009, we expect our partner Nycomed to initiate the first phase 1 clinical trial with MT203, a GM-CSF-neutralizing human monoclonal antibody, for the treatment of chronic inflammatory and autoimmune diseases.
  • Later in 2009, we expect our partner Morphotek, a wholly-owned subsidiary of Eisai, to initiate a first phase 1 clinical trial with MT228, a glycolipid-binding human antibody.
  • Also later in 2009, we expect our partner TRACON Pharmaceuticals, Inc. to complete the ongoing phase 1 clinical trial of MT293, a humanized monoclonal antibody targeting denatured collagen, that is being developed for the treatment of solid tumors.
  • Micromet intends to publish results from the research and development of its programs in peer-reviewed scientific and clinical journals throughout the year.
  • As previously stated, Micromet entered into an agreement with Bayer Schering in January 2009 under which Bayer Schering has obtained an exclusive option to develop and commercialize a BiTE antibody against a specified solid tumor target. We intend to enter into at least one additional corporate collaboration in 2009.
  • Financial Results:

    Quarter Ended December 31, 2008

    For the three months ended December 31, 2008, Micromet recognized total revenues of $5.9 million, compared to $7.0 million for the same period in 2007. Total operating expenses were $12.4 million for the three months ended December 31, 2008, compared to $13.1 million for the same period in 2007.

    Loss from operations for the three months ended December 31, 2008 was $6.5 million, compared to a loss from operations of
    '/>"/>

    SOURCE Micromet, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. Micromet, Inc. Reports Third Quarter 2008 Financial Results
    2. Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results
    3. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
    4. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
    5. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
    6. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
    7. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
    8. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
    9. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
    10. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
    11. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... , July 31, 2014 The SNIS ... with $25,000 to fund a translational research project.  ... 2011, the gift was presented at the Society ... Meeting in Colorado Springs, CO. ... neurointerventional approaches to neurovascular conditions, SNIS formed the ...
    (Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® bearings ... are uniquely suited to prevent loss of lubrication that ... high temperatures . , Recently, a manufacturer of ... at Graphite Metallizing to overcome problems with movement of ... pans containing blocks of powder mixture are loaded onto ...
    (Date:7/31/2014)... -- Research and Markets has announced the ... report to their offering. ... the genetic material or genomes of an organism. It ... discovery and development of diagnostic and therapeutic solutions for ... is supported by three major product segments: Instruments, Consumables, ...
    (Date:7/31/2014)...  Smith & Nephew (LSE:SN, NYSE: ... announced its entry into the forefoot market with ... System. Comprised of three separate repair options, the ... repair and reconstruction, a metatarsal osteotomy guide, and ... fusion, also known as hammer toe correction. ...
    Breaking Biology Technology:SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4
    ... Advanstar|CBI recently announced the full agenda for their ... takes place March 6-7, 2012 in Baltimore, MD. ... Lilly, Genentech, AstraZeneca, Shire Human Genetic Therapies and many ... Meds recently interviewed PAP,s Senior Program Manager, Sharon Langan. ...
    ... Jan. 9, 2012   Veracyte, Inc ., a ... molecular cytology, today announced that Palmetto GBA, a ... coverage for the company,s Afirma Gene Expression Classifier ... that Veracyte,s genomic test is now accessible to ...
    ... Chembio Diagnostics, Inc. (OTC.PK: CEMI and OTC.QB: ... diagnostic tests, today announced that Lawrence A. Siebert, President ... Showcase in San Francisco at approximately 5:30 pm Eastern ... 2012.   The conference will be simultaneously ...
    Cached Biology Technology:Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis 2Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis 3Chembio Presenting at Biotech Conference 2Chembio Presenting at Biotech Conference 3
    (Date:7/31/2014)... German . , ... a sponge that soaks up liquids. Hence, these highly ... gases. However, loading of many MOFs is inhibited by ... report in Nature Communications that the barriers ... can be prevented by water-free synthesis and storing strategies. ...
    (Date:7/31/2014)... 2014 -- Do people make a rational choice to ... that way? Is it a matter of genetics?, Two ... colleague from Rice University say that neither conscious decision-making ... left while others lean right. , A growing body ... are at the core of political differences, the researchers ...
    (Date:7/31/2014)... the photovoltaic effect in 1839, humankind has sought to ... its own purposes. In a new research report published ... FASEB Journal , scientists may have uncovered a ... focusing on a naturally occurring combination of lipids that ... over time and across speciessuggests that this specific natural ...
    Breaking Biology News(10 mins):Free pores for molecule transport 2Scientists find growing consensus: Political attitudes derive from body and mind 2Scientists shine bright new light on how living things capture energy from the sun 2
    ... as fit as the people of ancient Athens, despite all ... by University of Leeds (UK) exercise physiologist, Dr Harry Rossiter. ... rowing a reconstruction of an Athenian trireme, a 37m long ... portable metabolic analysers, he measured the energy consumption of a ...
    ... tiny piece of genetic code apparently goes where no bit ... its own internal code. , A report on the renegade ... be published Jan. 5 in Science. , MicroRNAs, already ... gum up larger strands of RNA that carry instructions for ...
    ... predict the color of plants on planets in other solar ... live on extra-solar planets, according to scientists whose two scientific ... The scientists studied light absorbed and reflected by organisms on ... the light given off by planets circling distant stars, they ...
    Cached Biology News:Fitness has fallen since the days of Ancient Greece 2Renegade RNA -- Clues to cancer and normal growth 2NASA predicts nongreen plants on other planets 2NASA predicts nongreen plants on other planets 3
    Cultrex 3D Culture Matrix Laminin I....
    mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
    ...
    ... GeneMaths XT is undoubtedly the most ... Its advanced concept of layers and subsets ... different layers for different data outputs, for ... values, etc., as well as different subsets ...
    Biology Products: